Dr. David E. Griffith, MD

Dr. Griffith practices at National Jewish Health in Denver, Colorado, part of National Jewish Health.

Dr. Griffith's NPI, 1245229301, was assigned on October 20, 2005. Dr. Griffith graduated from St. Louis College of Physicians and Surgeons in 2002. Dr. Griffith holds Colorado license 64427.

Dr. Griffith's primary practice is National Jewish Health, at 1400 Jackson St, Denver, CO 80206 in Denver County. The practice phone is (303) 388-4461.

Dr. Griffith's primary practice is National Jewish Health in Denver, Colorado, part of National Jewish Health. Dr. Griffith is also affiliated with Saint Joseph Hospital. The medical group on file is National Jewish Health. Dmand AI also links Dr. Griffith to 1 more hospital and 1 medical group, each named with a free account. Dr. Griffith's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Griffith practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Griffith's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Griffith is licensed in Colorado.

CMS data shows 346 Medicare services from Dr. Griffith across 3 procedure codes in 2024, all of them office visits, for 170 Medicare patients. Medicare paid $33,557 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 170 Medicare patients who saw Dr. Griffith in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have copd, and 62% have high cholesterol. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Griffith's median patient age at 73, with 84% women.

In 2024, Dr. Griffith wrote 473 Medicare Part D claims for 116 patients. 76% of them were for generic drugs. CMS names the drug for 371 of them, across 10 drugs with 11 or more claims each, at $584,799 in total drug cost. In 2023, CMS named 536 claims across 12 drugs.

Dr. Griffith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Griffith as offering telehealth.

Dmand AI links 106 papers to Dr. Griffith, published from 2003 to 2025. 2016 was the busiest year, with 8. The most frequent topics are Mycobacterium Infections, Nontuberculous, Lung Diseases and Anti-Bacterial Agents. Dr. Griffith has published most often in Chest. Dr. Griffith's most frequent co-authors are Kevin Loring Winthrop, MD, Charles L. Daley, MD and Richard James Wallace, MD.

Dmand AI links Dr. Griffith to 4 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Mycobacterium Infections, Nontuberculous, Mycobacterium avium-intracellulare Infection and Bronchiectasis. Kevin Winthrop sponsors the most, 2.

CMS Open Payments shows 327 general payments to Dr. Griffith from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Insmed, Inc. paid the most, $238,260.

Dr. Griffith graduated from St. Louis College of Physicians and Surgeons in 2002.